SCHEMBL29914860

SCHEMBL29914860

Cc1c[nH]c(=O)c2ccc(B(O)O)cc12

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ROCK1 Q13464 2/20 0.41
▸ CA2 P00918 2/20 0.35
▸ LPL P06858 1/20 0.35
▸ LIPG Q9Y5X9 1/20 0.35
▸ ENPP2 Q13822 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ DAO P14920 3/20 0.34
▸ AR P10275 1/20 0.33
▸ AKR1C3 P42330 1/20 0.33
▸ PARP1 P09874 2/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ RPS6KA3 P51812 1/20 0.33
▸ ATAD2 Q6PL18 1/20 0.32
▸ PRMT5 O14744 1/20 0.32
▸ WDR77 Q9BQA1 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27159981 1.00 ROCK1 (0.41) ROCK1CA2LPLLIPGENPP2
SCHEMBL30816158 0.80 AR (0.42) ROCK1CA2ENPP2KDM4EDAO
SCHEMBL27159792 0.80 AR (0.42) ROCK1CA2ENPP2KDM4EDAO
SCHEMBL3680891 0.77 ATM (0.47) CA2LPLLIPGENPP2KDM4E
SCHEMBL4009027 0.77 AR (0.53) ROCK1KDM4EDAOARAKR1C3
SCHEMBL30869524 0.77 ATM (0.47) CA2LPLLIPGENPP2KDM4E
SCHEMBL12851129 0.74 PARP1 (0.46) ROCK1KDM4EDAOARAKR1C3
SCHEMBL1710385 0.74 CHEK1 (0.46) ROCK1CHEK1PIM1RPS6KA3
SCHEMBL17301314 0.74 ROCK1 (0.47) ROCK1KDM4EPARP1CHEK1PIM1
SCHEMBL27159759 0.73 DAO (0.32) DAOATAD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240425479-A1 HALO-SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-12-26 — — US disclosed
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 — — US disclosed
EP-4330246-A1 HALO-SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) Ontario Institute for Cancer Research (OICR) (CA) 2024-03-06 — — EP disclosed
CN-117597336-A Halogen substituted amino aza-heteroaryl compounds as inhibitors of hematopoietic progenitor kinase 1 (HPK 1) 安大略省癌症研究所(OICR) 2024-02-23 — — CN disclosed
WO-2022226665-A1 HALO-SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 — — WO disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 ROCK1 2653/4885CA2 2505/4885LPL 3952/4885
US-20240425479-A1 HALO-SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) DCK, CMPK1, WNK1 ROCK1 2846/4885CA2 3632/4885LPL 2634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback